Achieve Life Sciences Inc. [NASDAQ: ACHV] stock went on an upward path that rose over 7.26% on Friday, amounting to a one-week price increase of more than 10.67%. The company report on January 7, 2021 that Achieve Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference.
Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, announced that John Bencich, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Conference being held virtually January 11-14, 2021.
A webcast of the presentation will be available on Monday, January 11th at 6:00 AM EST and can be accessed by visiting the Achieve Investor Relations page http://ir.achievelifesciences.com/events-and-webcasts.
Over the last 12 months, ACHV stock dropped by -18.68%. The average equity rating for ACHV stock is currently 1.70, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $52.36 million, with 3.29 million shares outstanding and 3.20 million shares in the current float. Compared to the average trading volume of 213.09K shares, ACHV stock reached a trading volume of 387629 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Achieve Life Sciences Inc. [ACHV]:
The Average True Range (ATR) for Achieve Life Sciences Inc. is set at 0.47 The Price to Book ratio for the last quarter was 1.25.
ACHV Stock Performance Analysis:
Achieve Life Sciences Inc. [ACHV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.67. With this latest performance, ACHV shares gained by 23.42% in over the last four-week period, additionally plugging by 13.90% over the last 6 months – not to mention a drop of -18.68% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ACHV stock in for the last two-week period is set at 69.88, with the RSI for the last a single of trading hit 78.20, and the three-weeks RSI is set at 63.68 for Achieve Life Sciences Inc. [ACHV]. The present Moving Average for the last 50 days of trading for this stock 8.41, while it was recorded at 9.21 for the last single week of trading, and 8.56 for the last 200 days.
Insight into Achieve Life Sciences Inc. Fundamentals:
Return on Total Capital for ACHV is now -96.55, given the latest momentum, and Return on Invested Capital for the company is -96.38. Return on Equity for this stock declined to -96.86, with Return on Assets sitting at -81.64. When it comes to the capital structure of this company, Achieve Life Sciences Inc. [ACHV] has a Total Debt to Total Equity ratio set at 2.01. Additionally, ACHV Total Debt to Total Capital is recorded at 1.97, with Total Debt to Total Assets ending up at 1.72. Long-Term Debt to Equity for the company is recorded at 0.88, with the Long-Term Debt to Total Capital now at 0.86.
Reflecting on the efficiency of the workforce at the company, Achieve Life Sciences Inc. [ACHV] managed to generate an average of -$1,171,071 per employee.Achieve Life Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.00 and a Current Ratio set at 13.00.
ACHV Stock EPS
With the latest financial reports released by the company, Achieve Life Sciences Inc. posted -6/share EPS, while the average EPS was predicted by analysts to be reported at -6.4/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 6.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ACHV.
Achieve Life Sciences Inc. [ACHV] Insider Position Details
There are presently around $4 million, or 21.00% of ACHV stock, in the hands of institutional investors. The top three institutional holders of ACHV stocks are: IKARIAN CAPITAL, LLC with ownership of 284,151, which is approximately 55.336% of the company’s market cap and around 0.48% of the total institutional ownership; REQUISITE CAPITAL MANAGEMENT, LLC, holding 50,000 shares of the stock with an approximate value of $0.49 million in ACHV stocks shares; and BOOTHBAY FUND MANAGEMENT, LLC, currently with $0.33 million in ACHV stock with ownership of nearly New of the company’s market capitalization.
Positions in Achieve Life Sciences Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 9 institutional holders increased their position in Achieve Life Sciences Inc. [NASDAQ:ACHV] by around 199,446 shares. Additionally, 10 investors decreased positions by around 196,917 shares, while 4 investors held positions by with 56,276 shares. The mentioned changes placed institutional holdings at 452,639 shares, according to the latest SEC report filing. ACHV stock had 9 new institutional investments in for a total of 82,004 shares, while 7 institutional investors sold positions of 194,344 shares during the same period.